Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | CYP4A11 | Q02928 | 5/20 | 0.56 |
| ▸ | CYP4F2 | P78329 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11039774 | 0.90 | KMT2A (0.53) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| SCHEMBL9818052 | 0.88 | KMT2A (0.73) | KMT2AHSD17B10LMNAMMP12MMP13 | |
| SCHEMBL9253282 | 0.87 | HSD17B10 (0.67) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| SCHEMBL9253738 | 0.85 | CYP4A11 (0.66) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| Methane SCHEMBL10448934 | 0.85 | HSD17B10 (0.65) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| Acetophenone SCHEMBL8048362 | 0.85 | TDP1 (0.64) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| SCHEMBL17457887 | 0.84 | HSD17B10 (0.74) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| SCHEMBL11424105 | 0.84 | HSD17B10 (0.74) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| SCHEMBL9445340 | 0.84 | CYP4A11 (0.64) | KMT2AHSD17B10CYP4A11CYP4F2LMNA | |
| SCHEMBL28560062 | 0.84 | CYP4A11 (0.64) | KMT2AHSD17B10CYP4A11CYP4F2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132606-A1 | NOVEL ISOINDOLINONE DERIVATIVE COMPOUNDS AS CASPASE INHIBITORS | 주식회사 이노보테라퓨틱스 | 2023-07-13 | — | — | WO | disclosed |
| US-11518733-B2 | Process for preparation of highly pure Fingolimod hydrochloride | SHIVALIK RASAYAN LIMITED (IN) | 2022-12-06 | — | — | US | disclosed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-111517902-B | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-112694449-B | Asymmetric hydrogenation of ketone and alpha, beta-unsaturated ketone catalyzed by nonmetal catalyst | 中国科学院化学研究所 | 2022-05-24 | — | — | CN | disclosed |
| CN-112694449-A | Novel nonmetal catalyst for catalyzing asymmetric hydrogenation of ketone and alpha, beta-unsaturated ketone | 中国科学院化学研究所 | 2021-04-23 | — | — | CN | disclosed |
| CN-111517902-A | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2020-08-11 | — | — | CN | disclosed |
| EP-2168944-B1 | AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-11 | — | — | EP | disclosed |
| CN-101730677-B | Amine compound and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORP | 2014-07-16 | — | — | CN | disclosed |
| US-20120316208-A1 | INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE THWART MYCOBACTERIAL GROWTH | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-12-13 | — | — | US | disclosed |
| US-20090011154-A1 | THERMAL TRANSFER IMAGE-RECEIVING SHEET AND SURFACE CONDITION IMPROVER | FUJIFILM CORPORATION (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20060211891-A1 | Metal catalyst and its use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-09-21 | — | — | US | disclosed |
| CN-1805788-A | Metal catalyst and its use | SUMITOMO CHEMICAL CO (JP) | 2006-07-19 | — | — | CN | disclosed |
| EP-1618953-A1 | METAL CATALYST AND ITS USE | Sumitomo Chemical Company, Limited (JP) | 2006-01-25 | — | — | EP | disclosed |
| US-5385693-A | Having rapid response and low phase transition temperature | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0357372-B1 | Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element | SUMITOMO CHEMICAL CO (JP) | 1994-11-17 | — | — | EP | disclosed |
| US-5264151-A | Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-11-23 | — | — | US | disclosed |
| US-5124070-A | High speed response | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-06-23 | — | — | US | disclosed |
| EP-0357372-A2 | Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-03-07 | — | — | EP | disclosed |
| EP-0171040-A1 | P-Cyanobiphenylyl-[p-(omega-alkoxyalkyl)]-benzoate compound and liquid crystal material | CASIO COMPUTER COMPANY LIMITED (JP) | 1986-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211891-A1 | Metal catalyst and its use | SOD1, NOX4, MVD | KMT2A 2086/4885HSD17B10 3480/4885CYP4A11 2087/4885 |
| US-20120316208-A1 | INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE THWART MYCOBACTERIAL GROWTH | UGDH, UGGT1, UMPS | KMT2A 3592/4885HSD17B10 1927/4885CYP4A11 3074/4885 |
| US-11518733-B2 | Process for preparation of highly pure Fingolimod hydrochloride | S1PR5, S1PR4, S1PR1 | KMT2A 336/4885HSD17B10 3343/4885CYP4A11 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.